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Summary
Background: The wireless motility capsule concurrently measures temperature, pH
and pressure as it traverses the gastrointestinal tract.
Aims: To describe normative values for motility/contractility parameters across age,
gender and testing centres.
Methods: Healthy participants underwent a standardised wireless motility capsule
assessment following an overnight fast and consumption of a meal of known nutri-
tional content. Traces were divided into regions of interest and analysed using 2
software packages (MotiliGI and GIMS Data Viewer). Inter-observer agreement was
independently assessed by 2 investigators.
Results: Normative data for motility/contractility parameters (maximum amplitude,
mean peak amplitude, contraction frequency and motility index) are presented for
107 individuals (62 male, median age 40 years, range 18-78). MotiliGI-Gastric, small
bowel and colonic maximal contraction amplitude correlated with age (r = .24,
P = .01; r = .22, P = .02; and r = .2, P = .04 respectively). Small bowel motility index
was higher in females than males (150.4  12 vs 122  7.6, P = .04). Inter-obser-
ver agreement was excellent for transit times, pH and contractility/motility parame-
ters. GIMS Data viewer-Gastric, small bowel and colonic loge motility index
correlated with the respective area under the contraction curve, total contractions,
sum of amplitudes and contraction frequency (all r>.35, P < .0003) but not with
transit times.
Conclusions: Our analysis provides normative data for motility/contractility parame-
ters. Log motility index summarises a number of measures. In future, the measure-
ment of contractile activity with the wireless motility capsule may potentially aid in
the diagnosis of disease states such as visceral myopathic disorders.
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1 | INTRODUCTION
Gastrointestinal (GI) motility can be considered as movements within
the digestive system and transit of contents across the absorptive
and secretary surface. This process is coordinated and regulated
through a complex circuitous interaction between a numbers of sys-
tem including, but not limited to, the enteric, autonomic and central
nervous systems. When aberrancies occur in any of these, it may
result in disruption of the coordination of propulsive peristalsis,
potentially leading to dysmotility and ultimately symptoms.1 How-
ever, dysmotility has been used to describe a plethora of abnormali-
ties, which are not purely limited to alterations in transit but may
also result in changes in GI sensorimotor activity.2
Currently, our understanding of GI motility, both in health and
disease, has been limited by the relative inaccessibility of certain
portions of the GI tract.3 Although several techniques are available
to evaluate such regions, many of these primarily measure only
transit times, although it is well recognised that these poorly pre-
dict symptoms.4 Technological developments, such as those seen
with high-resolution manometric techniques, have facilitated the
concurrent evaluation of both motility as well as contractility pat-
terns.5,6 While these techniques are considered to be the gold
standard, by definition they necessitate the placement of an intra-
luminal catheter which can cause a transient disturbance in the
underlying regulatory neural systems that control motility.7 Further-
more, particularly for the assessment of large bowel function, stud-
ies need to be of relatively long duration (>24 hours), can
necessitate colonoscopy and sedation (that may potentially influ-
ence motility) and require the subject under study to be confined
to the laboratory.8
Therefore, techniques that measure both contractility and motil-
ity that do not require an intraluminal catheter provide an alternative
and more attractive method of describing normal and abnormal GI
physiology.5,9 To be clinically applicable, such techniques should be
standardised, reproducible and easily interpretable as well as accept-
able to the patient. In this regard, the wireless motility capsule has a
number of salient advantages.10,11 For instance, it is minimally inva-
sive, ambulatory and does not require exposure to ionising radiation.
Additionally, the wireless motility capsule has been demonstrated to
be sensitive and specific technique in measuring pan-enteric and
regional transit is comparable to conventional methods and has
robust normal ranges for transit times and pH.11-13 The wireless
motility capsule has been approved for use in the USA by the Food
and Drug Administration for investigating suspected delayed gastric
emptying and chronic constipation.14 In addition to measuring tem-
perature and pH, the wireless motility capsule also measures intralu-
minal pressure as it traverses the GI tract.10,14 However, this has
received scant attention in the literature to date. Moreover, the
inter-observer agreement of contractility measures has not been
comprehensively described.15 The primary aim of this study was to
define normative ranges for regional and contractility/motility mea-
sures. Our secondary aims were to evaluate the inter-observer
agreement between transit times, pH profile and contractility/
motility parameters as well as investigating the co-relationship
between these and the motility index.
2 | MATERIALS AND METHODS
2.1 | Study population
The study population consisted of 109 healthy participants who
underwent wireless motility capsule testing in studies performed in
the UK (14/109), Sweden (22/109) and the USA (73/109). The data
from the USA were collected during a multi-centre clinical trial eval-
uating GI transit as measured by the wireless motility capsule in
comparison to radio-opaque markers and has been published else-
where.16 The data from Sweden were collected as part of the pro-
cess for deriving normative transit values.12 The data from the UK
were derived from the baseline recordings in healthy subjects of a
clinical trial programme investigating the promotile drug camicinal.17
The respective Institutional Review Boards, or Ethical Committees,
approved all studies at the study centres. Each participant provided
written informed consent. Participants were included if they were
between 18 and 80 years old, with no concurrent or past medical
history of cardiovascular, endocrine, renal, gastroenterological, liver,
respiratory or any other chronic disease or currently taking any med-
ications (prescribed or over the counter). Participants were also
required to have a normal bowel habit, defined as a complete spon-
taneous bowel movement at least once per 48 hours for the pur-
poses of this study. Participants were excluded if there was a known
absolute or relative contraindication to undergoing a wireless motil-
ity capsule study (such as previous GI surgery, clinical evidence of
diverticulitis), if there was a history of GI symptoms or if they had a
body mass index >35 kg/m2, were pregnant or had a planned mag-
netic resonance imaging (MRI) procedure during the study. Partici-
pants were instructed to refrain from tobacco and alcohol use for
24 hours prior to wireless motility capsule ingestion and during the
study period.
2.2 | Wireless motility capsule
The wireless motility capsule (SmartPill, Medtronic, Minneapolis,
USA) has been described elsewhere.13,18 In brief, the wireless motil-
ity capsule system consists of an indigestible single-use capsule, an
external portable data receiver, a docking station and bespoke dis-
play and analysis software. The wireless motility capsule contains 3
sensors: (1) a pH sensor capable of measuring pH in the range of
0.5 to 9.0 pH units with an accuracy  0.5, (2) a pressure transducer
capable of measuring pressures ranging from 0 to 350 mm Hg with
an accuracy of  5 mm Hg below 100 mm Hg and  10 mm Hg at,
or above, 100 mm Hg and (3) a temperature sensor capable of mea-
suring temperatures ranging from 25 to 49°C with an accuracy
of  1°C. After activation, calibration and ingestion, pH, pressure
and temperature are continuously measured as the wireless motility
capsule traverses the GI tract. Data from the sensors are transmitted
at 434 MHz to the portable data receiver worn by the participants.
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Data are stored within the receiver and can be downloaded to a
personal computer, using a USB docking station, for subsequent
analysis.
2.3 | Wireless motility capsule testing protocol
After an overnight fast, participants ingested a standardised meal
consisting of known nutritional content (SmartBar, Medtronic,
Minneapolis, USA, 260-kcal, composed of 3% fat, 21% protein and
75% carbohydrate, 3% of which as fibre) with 50 mL of water.
Following this meal, participants ingested the wireless motility cap-
sule which had been previously calibrated and activated as per the
manufacturer’s instructions. Participants were then asked to refrain
from eating for the next 6 hours and avoid strenuous physical
activity. After 6 hours, participants were permitted to resume their
daily activities and diet. During the recording period, participants
were asked to record bowel movements, food intake/meal times,
GI symptoms (if any) and sleeping times on the portable data
receiver.
2.4 | Wireless motility capsule data analysis
2.4.1 | Definition of anatomical landmarks
Each participant’s wireless motility capsule data were downloaded
onto a personal computer (Dell, Bracknell, Berkshire, UK) and anal-
ysed using the manufacturer supplied analysis software (MotiliGI,
version 3.0.20, Medtronic, Minneapolis, USA). The GI tract was
divided into 3 regions based on the identification of stereotypical
landmarks, based on pH and temperature measures, as per the
method proposed by Sarosiek et al.19 In brief, the gastric region and
gastric emptying time were defined from capsule ingestion, which is
associated with a sharp temperature rise to 37°C, until a steep pH
rise (>3 pH units) from gastric baseline to a pH greater than 4.0 pH
units, reflecting passage across the pylorus. The small bowel region
and small bowel transit time were defined as from this point until
passage across the ileocaecal junction (ICJ), characterised a sustained
drop in pH greater than 1 pH unit, and sustained for at least 10 min-
utes.18 Finally, the colonic region and colonic transit time were
defined from this point until capsule expulsion, verified by a charac-
teristic temperature drop from body temperature to room tempera-
ture, see Figure 1.
2.4.2 | Motility and contractility measures
Motility and contractility measures were calculated using 2 pieces of
proprietary software (MOTILIGI, version 3.0.20, and GIMS Data Viewer,
version 3.0.0, Medtronic, Minneapolis, USA). MotiliGI—the contrac-
tility and motility measures provided by the software include maxi-
mum amplitude of contractions, mean peak amplitude of
contractions, contractions per minute and the MI. The MI combines
a number of pressure measures into one metric. The MI is deter-
mined according to the method proposed by Ouyang et al whereby
the summation of the area under the amplitude curve for contrac-
tions about 10 mm Hg above baseline, calculated as the amplitude
of the reading multiplied by the duration of the reading divided by
the time window and expressed in units of mm Hg*second/min-
ute.20 This is equivalent to the sum of the amplitudes of all the con-
tractions multiplied by their duration in a given segment, thus
providing a time-based summary measure. MotiliGI is user friendly
and provides a “wizard” which aids in the performance of semi-auto-
mated analysis. GIMS Data viewer provides total number of contrac-
tions, frequency of contractions, area under of the curve (AUC) of
contractions, sum of amplitudes and loge MI. The AUC represents
the integral of the contraction amplitudes over time. The loge MI is
derived from the natural log of the (sum of amplitudes x number of
contractions +1) as determined by Camilleri et al in healthy individu-
als in whom concomitant antral manometry and scintigraphy was
undertaken after ingestion of a radiolabelled solid and liquid meal.21
The software calculates loge MI over the segment of interest, ie, gas-
tric, small bowel and colon, as previous studies have suggested that
the cumulated slope is linear.22 The loge MI therefore provides
amplitude-based summary measure. GIMS Data viewer has been
designed for research use. Pan-enteric data are shown in the Data
S1.
2.5 | Inter-observer agreement
Inter-observer agreement was assessed in all participants. Traces
were independently analysed by 2 observers (ADF and CBH).
2.6 | Statistical analysis
The motility/contractility measures are summarised using the num-
ber of observations, mean and standard deviation. To evaluate the
effect of gender, age and study country on the study endpoints, a
multiple linear regression model was used. Reference ranges for
the motility parameters were derived from the 5th to 95th per-
centiles. Agreement between observers was compared using the
intra-class correlation coefficient, and Bland-Altman’s limits of
agreement. A 2-way, random effects, single measure intra-class cor-
relation coefficient model was used and interpreted according to
Yen et al. using the following criteria: <0.40 = poor, 0.40-
0.59 = fair, 0.60-0.74 = good, 0.75-1.00 = excellent.23 Limits of
agreement includes both random error (precision) and systematic
error (bias), providing a useful measure for comparing the differ-
ence between 2 observations and is expressed as a 95% confi-
dence interval of the difference. Correlational analyses were
performed to investigate the contribution of contractility parame-
ters to MI and transit times and are reported using Pearson’s (r) or
Spearman’s coefficient (rs) dependant on data distribution. Given
that this analysis was exploratory, we did not correct for multiple
testing. Two-tailed tests were used throughout. P < .05 was
adopted as the criterion for statistical significance. All analyses
were performed using proprietary software (STATA, Version 14, Col-
lege Station, TX, USA).
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3 | RESULTS
3.1 | Participant characteristics
A total of 109 individual wireless motility capsule data files were
available. Of these, 2 were excluded due to major signal loss. Of the
remaining 107 individual wireless motility capsule data files, 62 were
male with a median age of 40 years, range 20-78, and 45 females
with a median age of 38 years, range 18-74.
3.2 | Regional transit times and pH profile
The mean gastric emptying time, small bowel transit time, colonic
transit time and whole gut transit time were 194  118 minutes,
262  107 minutes, 1474  1112 minutes and 1930  1158 min-
utes respectively. There were no gender or country differences in
gastric emptying time, small bowel transit time, colonic transit time
and whole gut transit time. Age weakly positively correlated with
prolonged wireless motility capsule (r = .2, P = .04). The mean gas-
tric, small bowel and colonic pH were 2.4  1.5, 6.9  1 and
6.8  1.1 respectively. No gender, age or country differences were
seen.
3.3 | Motility/contractility measures—MotiliGI
Motility and contractility measures derived from MotiliGI are shown
in Table 1. Gastric (r = .24, P = .01), small bowel (r = .22, P = .02)
and colonic (r = 0.2, P = .04) maximal pressures correlated with age.
The small bowel motility index was higher in females than males
(150.4  12 vs 122  7.6, P = .04). No other gender or country dif-
ferences were evident. As expected based on their calculations, the
respective gastric, small bowel and colonic motility indices correlated
with the gastric (r = .65, P < .0001), small bowel (r = .6, P < .0001)
and colonic (r = .6, P < .0001) mean contraction amplitude. As
expected based on their calculations, the gastric, small bowel and
colonic MI correlated with their respective gastric (r = .72,
P < .0001), small bowel (r = .8, P < .0001) and colonic (r = .5,
P < .0001) mean contraction frequency. Gastric emptying time corre-
lated with gastric MI (r = .4, P < .0001). Small bowel transit time and
colonic transit time did not correlate with their respective MI.
3.4 | Motility/contractility measures—GIMS
Motility and contractility measures derived from GIMS are shown in
Table 2. The number of contractions within a segment positively
correlated with gastric emptying time, small bowel transit time and
colonic transit time (rs = .36, P < .0001; rs = .64, P < .0001; and
rs = .74, P < .0001). The respective AUC correlated with gastric
emptying time, small bowel transit time and colonic transit time
(rs = .63, P = .0003; rs = .51, P < .0001; and rs = .69, P < .0001). As
expected based on their calculations, gastric loge MI correlated with
gastric AUC, total contractions, sum of amplitudes and frequency
(r = .86 P = .0001; r = .87 P = .0001; r = .88 P = .0001; r = .61
P = .0001 respectively). Gastric emptying time did not correlate with
gastric loge MI. Female gender was associated with a higher gastric
loge MI (14  1.5 vs 13.2  1.4, P = .002) but there was no associa-
tion with age or country. As expected based on their calculation,
small bowel loge MI correlated with small bowel AUC, total
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F IGURE 1 A typical tracing from a wireless motility capsule study. Time is recorded on the x-axis, pressure on the y1-axis (red line) and pH
on the y2-axis (green line) and temperature (blue line). The gastric region (GR), small bowel region (SBR) and colonic region (CR) are illustrated.
CI, capsule ingestion, P, pylorus, ICJ, ileocaecal junction, CE, capsule expulsion
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contractions, sum of amplitudes and frequency (r = .84 P = .0001;
r = .86 P = .0001; r = .91 P = .0001; r = .69 P = .0001 respectively).
Small bowel transit time did not correlate with small bowel loge MI.
Gender, age or country was not associated with small bowel loge MI.
As expected based on their calculations, colonic loge MI correlated
with colonic AUC, total contractions, sum of amplitudes and fre-
quency (r = .72 P = .0001; r = .87 P = .0001; r = .85 P = .0001;
r = .35 P = .0003 respectively). Colonic transit time did not correlate
with colonic loge MI, and gender, age or country was not associated
with colonic loge MI.
TABLE 1 Normative regional wireless motility capsule motility/contractility data using MotiliGI showing all and gender-specific means,
standard deviations, median and 5%-95% percentiles
Measure Gender Number Mean SD
5th
percentile
50th
percentile
95th
percentile
Gastric
Pressure maximum (mm Hg) All 107 241 103 65 241 434
Male 62 231 102 41 236 425
Female 45 25 103 99 256 467
Mean peak amplitude (mm Hg) All 107 3.3 3.3 1.8 2.7 6.6
Male 62 3.2 2.1 1.8 2.7 5.6
Female 45 3.6 2.4 1.8 3 9.9
Contractions per minute (number) All 107 1.7 1.2 0.5 1.3 4.2
Male 62 1.6 1.1 0.6 1.2 4.2
Female 45 1.9 1.3 0.5 1.7 5.2
Motility index (mm Hg*second/min) All 107 55 46 13 46 131
Male 62 53 45 13 45 138
Female 45 58 49 14 48 175
Small bowel
Pressure maximum (mm Hg) All 106 119 55 50 110 227
Male 61 123 58 45 119 229
Female 45 114 51 57 108 229
Mean peak amplitude (mm Hg) All 106 3.9 1.9 2.2 3.8 7.1
Male 61 3.6 1.2 1.6 3.6 5.5
Female 45 4.4 2.4 2.4 3.9 7.5
Contractions per minute (number) All 106 3.6 1.4 1.6 3.6 6.4
Male 61 3.4 1.3 1.5 3.2 6.1
Female 45 3.8 1.4 1.8 3.6 6.9
Motility index (mm Hg*second/min) All 106 134 70 58 126 286
Male 61 122 59 47 116 263
Female 45 150 81 63 136 381
Colon
Pressure maximum (mm Hg) All 106 155 47 90 147 236
Male 61 164 49 98 164 250
Female 45 143 41 83 139 224
Mean peak amplitude (mm Hg) All 106 4.5 1.9 2.1 4.2 7.2
Male 61 4.3 1.4 2.2 4 7.2
Female 45 4.7 2.4 2 4.5 8.3
Contractions per minute (number) All 106 2.2 0.9 1.1 2.1 4.4
Male 61 2.3 1 1.1 2 4.9
Female 45 2.1 0.7 1.1 2.1 3.7
Motility index (mm Hg*second/min) All 106 199 95 71 187 383
Male 61 197 93 70 182 399
Female 45 201 100 52 198 383
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TABLE 2 Normative regional wireless motility capsule motility/contractility data using GIMS showing all and gender specific means,
standard deviations, median and 5%-95% percentiles
Measure Gender Number Mean SD 5th percentile 50th percentile 95th percentile
Gastric
Total contractions (number) All 107 268 254 63 195 792
Male 62 208 160 63 153 556
Female 45 353 330 94 231 1045
Contraction per minute (number) All 107 1.5 1.3 0.4 1.2 3.9
Male 62 1.5 1 0.5 1.1 3.9
Female 45 1.7 1.5 0.4 1.4 3.6
Area under the curve All 107 9619 8771 1544 6471 32629
Male 62 7659 6537 1503 5930 21296
Female 45 12400 10683 3418 7106.7 33492
Motility index-natural log All 107 13.6 1.5 11.3 13.6 16.3
Male 62 13.3 1.4 11.3 13.2 14.1
Female 45 14.2 1.5 12.3 13.9 16.8
Sum of amplitudes All 107 5702 5030 2610 4146 6881
Male 62 4458 3345 1367 3563 11418
Female 45 7466 6373 2311 4716.8 18689
Small bowel
Total contractions (number) All 106 781 417 242 729 1567
Male 61 741 395 229 677 1486
Female 45 837 445 287 851 1821
Contraction per minute (number) All 106 3.5 1.5 1.5 3.3 6.4
Male 61 3.3 1.5 1.5 2.9 6.3
Female 45 3.7 1.5 2 3.6 6.3
Area under the curve All 106 26046 15161 7529 24799 56821
Male 61 24196 13841 8819 22189 54915
Female 45 28669 16672 9312 26631 56860
Motility index-natural log All 106 15.9 1.2 13.9 16.1 17.7
Male 61 15.8 1.3 13.8 15.9 17.5
Female 45 16.1 1.1 14.2 16.3 17.9
Sum of amplitudes All 106 14485 8068 4505 13361 30628
Male 61 13737 7631 4450 12203 27088
Female 45 15545 8629 5494 14421 32458
Colon
Total contractions (number) All 106 622 489 87 497 820
Male 61 559 408 102 464 1377
Female 45 712 579 61 577 1717
Contraction per minute (number) All 106 0.6 0.3 0.2 0.5 1.3
Male 61 0.6 0.3 0.3 0.6 1.3
Female 45 0.5 0.2 0.1 0.5 0.9
Area under the curve All 106 107640 119598 9095 73696 375574
Male 61 94570 116647 9916 58201 265957
Female 45 126181 122638 5137 97202 402153
Motility index-natural log All 106 16 1.7 12.6 16.2 18.5
Male 61 15.9 1.6 12.9 15.9 18.1
Female 45 16.2 1.9 11.9 16.6 18.9
(Continues)
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3.5 | Inter-observer agreement
Inter-observer agreement was assessed all participants, Table 3.
Intra-class correlation coefficient and limits of agreement showed
excellent reproducibility for majority of the measures.
4 | DISCUSSION
To date, this is the largest and most comprehensive dataset that
describes normative regional and motility/contractility parameters
using the wireless motility capsule. The wireless motility capsule has
become a popular method for measuring transit times due to is mini-
mally invasive nature in an ambulatory setting. However, normative
data only exist with regard to only a proportion of the wireless motility
capsule’s capabilities, ie transit times and regional pH.12 Despite this,
the wireless motility capsule also provides direct measurements of
regional motility/contractility measures, which may also be potentially
more useful clinically in evaluating GI motility. Nevertheless, these
have been largely ignored in the literature to date. In this study, we
have shown that the regional loge MI is a particularly useful summary
measure of contractility parameters given its robust correlations with
other regional measures such as AUC, total contractions, sum of
amplitudes and contraction frequency. Loge MI as reported in this
study, ie derived from the wireless motility capsule, is numerically sim-
ilar to that reported using an intraluminal catheter.21 Furthermore, we
demonstrate that many of these parameters have good inter-observer
agreement. Notably, it is clear from many of the motility/contractility
measures that there is a large variation in the normal ranges presum-
ably reflecting the diversity of “normal” GI tract physiology.
The GI tract is a complex organ, large parts of which are rela-
tively inaccessible, thus making it a challenge to assess in detail.3 A
number of other methods to assess transit times are currently avail-
able, such as scintigraphy,24 radio-opaque markers,25 the 3-D mag-
netic transit system,3 MRI26 and the wireless motility capsule.15
However, transit times per se may represent a blunt tool for evaluat-
ing GI motility as abnormalities that lead to symptoms can be more
subtle.3 Despite the functionality of the wireless motility capsule to
record pressure as it traverses the GI tract, the majority of studies
to date have not presented these data, arguably due to at least 3
factors. Firstly, due to the lack of availability of normative data, sec-
ondly due to challenges in calculating/extracting these parameters
and finally their relevance to symptoms. However, a recent study by
Barshop et al demonstrated that duodenal area under the pressure
curve was strongly and reproducibly associated with symptom sever-
ity in patients with both idiopathic and diabetic gastroparesis; these
findings warrant confirmation in larger more homogenous patient
groups.27 However, based on the normative data we present herein,
the values that they report would be within the normative range for
this metric, Table 2. Nevertheless, such detailed measures may pro-
vide alternative relevant physiological endpoints in clinical trials as it
is well described that transit times are not optimal to correlate with
symptoms.28 A number of techniques have been developed and
studied over the last 50 years utilising a variety of free-floating cap-
sule techniques including those containing radiopharmaceuticals and
pressure sensors.29,30 A more recently developed method is the 3D
transit system which, using an electromagnetic capsule, can delineate
pan-enteric and regional GI motility3. The marked advantage of this
system is that the location, velocity and direction of travel of the
capsule, relative to the receiver plate, is known at all times.4 While
this is a minimally invasive and ambulatory technique, the interpreta-
tion is labour-intensive and has yet to be validated in a large cohort
of healthy subjects and remains a research tool.3
There was little correlation between transit times and other con-
tractility measures. These data suggest that regional contractility and
transit times are not inextricably linked as measured using the wire-
less motility capsule. In a previous study reported by Hasler and col-
leagues, of 56 healthy controls and 36 constipated subjects, it was
demonstrated that colonic pressure activity increased from the proxi-
mal to distal colonic segments in all groups.31 However, when con-
sidering those subjects with the most severe slow transit
constipation, there was a marked reduction in this increase in pres-
sure activity albeit not associated with transit times.
We have demonstrated that the inter-observer agreement was
excellent for the majority of measures. This is in agreement with the
report by Rao et al who have previously described the intra-class
correlation coefficient for regional and whole gut transit times in 45
traces, composed of 10 healthy participants, 10 patients with gastro-
paresis and 25 patients with constipation.32 The authors demon-
strated excellent intra-class correlation coefficients between 3
independent observers. However, this study, to the best of our
knowledge, has only been published in abstract form and did not
encompass other motility/contractility measures derived from the
wireless motility capsule. Moreover, intra-class correlation coeffi-
cients in isolation cannot provide a complete picture of inter-obser-
ver agreement and should be accompanied by other parameters
such as limits of agreement, as included in our study.33
The process of analysing wireless motility capsule traces using
MotiliGI is relatively straightforward as it includes an analysis “wiz-
ard” which guides the clinician. While GIMS does not include this
feature, it does have enhanced functionality and provides a more
detailed analysis of wireless motility capsule traces in comparison to
MotiliGI. Thus, we would propose for routine clinical practice that
there is an inherent temporal advantage of using MotiliGI rather
TABLE 2 (Continued)
Measure Gender Number Mean SD 5th percentile 50th percentile 95th percentile
Sum of amplitudes All 106 26532 22376 3407 21587 67049
Male 61 23790 4138 4138 18597 54229
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than GIMS. For gastric emptying time, colonic transit time and whole
gut transit time, both Wang et al and Diaz-Tartera et al have
demonstrated a strong correlation between the results derived from
manual evaluation of wireless motility capsule traces and those
reported by an automated analysis from MotiliGI suggesting that
such an analysis is robust for clinical practice.12,34 In both of these
studies, the agreement between the automated assessment of small
bowel transit time was lower than the other transit measures argu-
ably due to the relative difficulty of identification of the ICJ.
This study is not without limitations. In contrast to high-resolu-
tion manometry, the absolute interpretation of parameters derived
from the wireless motility capsule is limited by the fact that it is cur-
rently not possible to detect a wave front, which represents a
propulsive peristaltic pattern. Given that the wireless motility capsule
is essentially a nonstatic “free-floating” pressure, pH and tempera-
ture transducer, the absolute clinical applicability of this normative
dataset is limited to luminal pressures and transit times, but cannot
detect the actual propagated pressure waves considered to be the
primary mechanism for propulsive motility. Therefore, it could be
cogently argued that the phasic contractile measurements delineated
by the wireless motility capsule do not significantly add to the infor-
mation of regional transit that can be measured by radio-opaque
markers and/or scintigraphy. Although whole gut transit time can be
measured with radio-opaque markers, which correlate reasonably
well with wireless motility capsule derived transit times, the wireless
motility capsule does offer the advantage of providing a regional
motility profile, encompassing the entirety of the GI tract in a single
ambulatory investigation.15 In the clinical environment, whether any
of these measures robustly and reproducibly associate with symp-
toms remains to be seen. The current study was undertaken using a
standardised test meal, and while this improves external validity with
respect to the normative data, no inferences can be made to these
values with respect to other meals of differing nutritional content. A
further limitation of our study was that we did not control for the
individual female’s stage of their menstrual cycle as this may influ-
ence GI motility.35 We had previously shown that female gender
was associated with longer gastric emptying time, colonic transit
time and whole gut transit time,12 although we did not demonstrate
any associations between gender and transit times in this study. The
reasons for this difference are unclear. Finally, the mean peak ampli-
tudes were lower than we would have expected in comparison to
previously reported stationary catheter studies36,37 and may limit the
identification of pathologically low amplitudes of contractions, such
as what is seen in connective tissue disorders such as scleroderma.38
In order to address this in future studies, an alternative approach
which would be to use maximal amplitudes although further studies
in clinical populations are needed.
In summary, this comprehensive analysis of the motility/contrac-
tility data provides normative motility/contractility data for the wire-
less motility capsule. Notably the loge MI provides a summary
TABLE 3 Inter-observer agreement of wireless motility capsule parameters showing observer median and inter-quartile range (IQR), intra-
class correlation coefficient (ICC) and Bland-Altman’s 95% limits of agreement (LOA)
Measure
Observer A (median
and (IQR))
Observer B (median
and (IQR))
ICC (95% confidence
interval)
Delta mean
(LOA)
Gastric
Pressure maximum (mm Hg) 241 (174-494) 240 (177-494) 0.99 (0.99-0.99) 0.02  1.5
Mean peak amplitude (mm Hg) 2.7 (2.3-3.5) 2.8 (2.4-3.5) 0.99 (0.99-0.99) 0.08  0.1
Contractions per minute 1.3 (1-2.1) 1.3 (1-2.1) 0.96 (0.91-0.99) 0.02  0.05
Motility index 46 (26-66) 46 (26-69) 0.99 (0.99-1.0) 0.3  0.3
Transit time 178 (132-221) 178 (136-221) 1 (1-1) 0.1  1.6
Median pH 2 (1.2-3.7) 2 (1.2-3.7) 0.99 (0.99-0.99) 0.03  0.05
Small bowel
Pressure maximum (mm Hg) 110 (83-141) 109.9 (84-141) 0.99 (0.99-0.99) 0.4  1.5
Mean peak amplitude (mm Hg) 3.8 (3-4.3) 3.9 (3.1-4.3) 0.99 (0.99-0.99) 0.01  0.1
Contractions per minute 3.3 (2.6-4.4) 3.4 (2.7-4.4) 0.4 (0.1-0.6) 0.1  0.1
Motility index 125 (87-161) 126 (91-163) 0.99 (0.99-0.99) 0.5  2.4
Transit time 240 (196-293) 240 (196-293) 0.7 (0.6-0.84) 0.3  0.8
Median pH 7 (6.6-7.4) 7 (6.7-7.4) 0.99 (0.99-0.99) 0.02  0.1
Colon
Pressure maximum (mm Hg) 147 (118-184) 147.1 (117.8-183.9) 0.99 (0.99-0.99) 0.1  0.8
Mean peak amplitude (mm Hg) 4.2 (3.5-5.2) 4.2 (3.5-5.2) 0.99 (0.99-0.99) 0.1  0.08
Contractions per minute 2.1 (1.7-2.6) 2.1 (1.7-2.6 0.99 (0.99-0.99) 0.1  0.07
Motility index 187 (128-267) 188 (129-265) 0.99 (0.99-0.99) 0.8  2.5
Transit time 1129 (850-1987) 1129 (850-1987) 0.93 (0.87 -0.93) 0.4  3
Median pH 6.9 (6.5-7.3) 6.9 (6.5-7.3) 0.99 (0.99-0.99) 0.03  0.06
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measure of many of these parameters. The measurement of contrac-
tile activity with the wireless motility capsule may advance our
understanding of novel pharmacological agents17 and potentially in
the diagnosis of disease states association with alterations in contrac-
tile amplitude, such as what is seen in visceral myopathic disorders.
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